ProteinLogic Ltd 

A diagnostic platform for immuno-fingerprinting human diseases


Nicolas Huber (See Profile)




Development, market readiness, clinical trial


United Kingdom

Patented technlology, 1 patent granted in US & EU, 2nd patent filed 2019, Freedom-to-operate established 2018.

Blood-based diagnostic for the ruling-out of Active Tuberculosis disease. No such diagnostic currently marketed.

We have received a letter of interest by QIAGEN for our unique TB diagnostic in combination with their products.

Our test performs equally well in hard-to-diagnose Extrapulmonary TB cases, exceeds WHO requirements.

Validated in-house with over 1000 clinical samples.

This information is confidential, do not share or copy.

Under evaluation at least till: 1st March

If you want to have more information or you want to review the project, you have to login or register


©2023 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

Aviso de cookies

Log in with your credentials


Forgot your details?

Create Account

Skip to toolbar